MRI

Latest News


CME Content


Osman Ratib, MD, PhD, FAHA, professor and chief of nuclear medicine in the Department of Radiology at the University Hospital of Geneva, discusses the advantages and future of the hybrid PET/MR modality.

Steven Kalkanis, MD, director of neurosurgical oncology at Henry Ford West Bloomfield Hospital, discusses how an MRI unit in the operating suite has transformed their approach to brain surgery.

University of Pennsylvania researchers have developed an experimental MRI contrast agent capable of targeting tumors, according to a report in the journal ACS Nano. Its coating, instead of targeting particular cancer receptors - which can be hit-or-miss and depend on the cancer - is attracted to the acidic environments in which tumors generally thrive.